Ignite Creation Date:
2025-12-24 @ 1:49 PM
Ignite Modification Date:
2026-01-05 @ 1:54 AM
Study NCT ID:
NCT02999295
Status:
COMPLETED
Last Update Posted:
2019-08-21
First Post:
2016-12-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1/2 Study of Ramucirumab Plus Nivolumab in Participants With Gastric or GEJ Cancer
Sponsor:
National Cancer Center, Japan
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01
Start Date Type:
ACTUAL
Primary Completion Date:
2017-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-08
Completion Date Type:
ACTUAL
First Submit Date:
2016-12-19
First Submit QC Date:
None
Study First Post Date:
2016-12-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-08-19
Last Update Post Date:
2019-08-21
Last Update Post Date Type:
ACTUAL